Log In
BCIQ
Print this Print this
 

SRK-015

  Manage Alerts
Collapse Summary General Information
Company Scholar Rock LLC
DescriptionInhibitor of latent myostatin (MSTN; GDF8) activation
Molecular Target Myostatin (MSTN) (GDF8)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard Indication Musculoskeletal (unspecified)
Indication DetailsTreat primary myopathies
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today